Stryker Announces They Have Released their Emergency Relief Bed™: A Limited-Release Medical Bed to Support Sritical Needs During a Pandemic

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Stryker has developed a low-cost, limited-release emergency response bed, Emergency Relief Bed™,  to quickly aid healthcare providers with efficient care during the COVID-19 pandemic.

Brad Saar, president of Stryker’s Medical division notes, “People are at the heart of what we do, and COVID-19 hasn’t changed that. It has amplified our mission of making healthcare better. We’re focused on meeting the supply needs of our customers so they can focus on taking care of patients right now. He concluded, “That’s why we raced to develop our Emergency Relief Bed, which will help emergency responders and caregivers move and position patients efficiently during this critical time.”

Stryker anticipates producing 10,000 beds a week to meet increased needs.

Stryker’s Emergency Relief Bed is a low-cost, readily available solution intended to serve those on the front lines – ranging from hospital emergency departments to triage and pop-up areas of care. It includes a six-inch-thick foam surface.

The Emergency Relief Bed features a 30-degree head of bed angle to accommodate patients in respiratory distress, including ventilated patients. It also features low height and an attached IV pole.

The bed is intended for use in the COVID-19 pandemic to support increased patient numbers in healthcare facilities. Stryker is actively pursuing making the bed available in select markets around the world.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.